Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Rodent and early human studies support feasibility of transcutaneous immunization

April 21, 1999

First CpG DNA-based immunotherapeutic enters human trials

April 20, 1999

Potential C. albicans vaccine tested in mice

April 20, 1999

Immune Response describes herpes vaccine research at FASEB 99

April 19, 1999

Compounds and methods for treating or diagnosing leishmaniasis disclosed by Corixa

April 16, 1999

Epimmune publishes studies on hepatitis, malaria vaccine development

April 12, 1999

SangStat's ciclosporin capsules filed for approval in U.K.

April 12, 1999

Fujisawa and NeXstar team up to identify new immunological agents

April 12, 1999

Addition of Canadian sites to phase III WF-10 AIDS trial approved

April 12, 1999

LeIF adjuvant enhances therapeutic efficacy of leishmaniasis vaccine in humans

April 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...